AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Plexus Vaccine, Inc., Appoints Scientific Advisory Board.(Brief Article)
2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Plexus Vaccine, Inc., San Diego, California, has selected six experts to serve on its Scientific Advisory Board.
Supporting Dr. Robert Deans, Plexus Vaccine's vice president of Research and Development, the Scientific Advisory Board will play a key role in helping the company employ Plexus Vaccine's Structural Pharmacogenomics technology to enable rapid and precise responses to infectious agents, including drug resistant and emerging pathogens.
"Because Plexus Vaccine will combine protein structural prediction, genomics, and bioinformatics into a rational approach to vaccine epitope discovery for genetic variants and cryptic pathogens, we require scientists from each of these disciplines to advise us on their respective areas of expertise. We believe that this diverse group of scientific advisors coupled with our proprietary Structural Pharmacogenomics technology will allow us to approach vaccine design in a rational and novel way,'' according ...
- Plexus Vaccine Inc Appoints Scientific Advisory Board Chaired by Roger Brent Of...
- Press release article from: PR Newswire November 1, 2001 700+ words
...Scientific Advisory Board. Supporting...Robert Deans, Plexus Vaccine's VP of Research...Chairman of the Plexus Vaccine Scientific Advisory Board. "It's...quality." Plexus Vaccine Scientific Advisory Board Advisor and...
- Plexus Vaccine Inc Forges Licensing Agreement With Molsoft LLC.
- Press release article from: PR Newswire September 11, 2001 700+ words
...modeling software and Plexus Vaccine's structure-based...Abagyan shall also join the Plexus Vaccine Board of Directors and Scientific Advisory Board. "Recent advances in...President & CEO of Plexus Vaccine. "Plexus will use a...
- Plexus Vaccine Inc Selected to Receive Department of Defense-Funded Competitive...
- Press release article from: PR Newswire February 8, 2002 700+ words
SAN DIEGO -- Plexus Vaccine Inc, a San Diego biotechnology...amp;D funding that enables Plexus Vaccine to acquire proof of concept for...platform technology. In addition, Plexus Vaccine will receive services, including...
- Plexus Vaccine Inc and GlaxoSmithKline Biologicals Sign Structure-Based...
- Press release article from: PR Newswire July 22, 2002 700+ words
SAN DIEGO -- Plexus Vaccine Inc announces that it has signed...funded research collaboration, Plexus Vaccine will design chimeric miniproteins...down-stream product rights. "Plexus Vaccine is establishing its leadership...
- Plexus Vaccine Acquires Exclusive Position for Demographically Targeted T-cell...
- Press release article from: PR Newswire June 19, 2002 700+ words
...DIEGO and COPENHAGEN, Denmark -- Plexus Vaccine Inc, a San Diego based biotechnology...Valley centered around Copenhagen. Plexus Vaccine, formed in 2001 and based in San Diego...For additional information about Plexus Vaccine, please visit the Company's web...
- SIGA TECHNOLOGIES, Inc. Announces Intent to Acquire PLEXUS VACCINE Inc. to...
- Press release article from: Business Wire April 1, 2003 700+ words
...letter of intent to acquire substantially all the assets of Plexus Vaccine Inc. The acquisition would expand SIGA's capabilities...developmental timelines". Susan Burgess, President and CEO of Plexus Vaccine, is also optimistic about the competitive strength gained...
- SIGA Technologies, Inc. Signs Definitive Agreement to Acquire Assets of Plexus...
- Press release article from: Business Wire May 15, 2003 700+ words
...acquire substantially all of the assets of San Diego based Plexus Vaccine Inc, including the equity in Plexus's Danish subsidiary...biowarfare defense". Susan Burgess, PhD, President and CEO of Plexus Vaccine will, upon consummation of the acquisition, be named as...
- SIGA EYES PLEXUS TO EXPAND BIOWARFARE DEFENSE RESEARCH.(SIGA Technologies to...
- Magazine article from: BIOWORLD Today Huggett, Brady April 2, 2003 700+ words
Byline: Brady Huggett , Senior Staff Writer SIGA Technologies is planning to buy Plexus Vaccine Inc., looking to expand its vaccine offerings and capitalize on government funding for the development of biowarfare defense...
Source: HighBeam Research, Plexus Vaccine, Inc., Appoints Scientific Advisory Board.(Brief...